NCT05199584 2026-03-05A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsEndeavor Biomedicines, Inc.Phase 2 Completed20 enrolled
NCT05800106 2023-04-10A Bioequivalence Study of Sunitinib Malate Capsules.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1 Completed24 enrolled
NCT00428220 2019-06-27A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.PfizerPhase NA Completed223 enrolled 8 charts
NCT00049023 2016-06-21Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid TumorsUniversity of IowaPhase 1 Completed27 enrolled
NCT00006368 2013-05-01Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerNovartisPhase 1 Completed60 enrolled